Ciaramella Giuseppe
SEC CIK 1786322 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | Pres, CSO | 253.9K | — | $16.55M | 31 | 2021-09-17 | 2026-06-17 |
Most active insiders at BEAM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FMR LLC | 10%, See Remark 1 | — | $10.05M |
| 2 | Evans John M. | CEO, Dir | — | $6.28M |
| 3 | Ciaramella Giuseppe | Pres | — | $1.41M |
| 4 | Bellon Christine | CLO | — | $881.0K |
| 5 | Simon Amy | Chief Medical Off | — | $606.7K |
| 6 | Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| 7 | Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-06-22 16:05 | 2026-06-17 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | M - OptEx | $0.964 | +35.5K | 253.9K | +16% | +$34.2K |
| T | 2026-04-06 17:34 | 2026-04-01 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale | $24.58 | -11.8K | 218.4K | -5% | -$290.3K |
| 2026-04-02 17:15 | 2026-03-31 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | A - Grant | $0.00 | +40.0K | 230.2K | +21% | $0 | |
| DT | 2026-02-26 | 2026-02-24 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | M - OptEx | $17.00 | +35.0K | 225.2K | +18% | +$595.0K |
| DT | 2026-02-26 | 2026-02-24 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale+OE | $32.00 | -35.0K | 190.2K | -16% | -$1.12M |
| T | 2025-04-03 | 2025-04-01 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale | $18.35 | -7,434 | 190.2K | -4% | -$136.4K |
| 2025-04-02 | 2025-03-31 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | A - Grant | $0.00 | +35.0K | 197.7K | +22% | $0 | |
| D | 2024-12-19 | 2024-12-17 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | M - OptEx | $0.67 | +53.5K | 162.7K | +49% | +$35.8K |
| T | 2024-11-08 | 2024-11-06 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale | $26.36 | -51.1K | 109.2K | -32% | -$1.35M |
| DMT | 2024-10-16 | 2024-10-14 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | M - OptEx | $2.00 | +41.8K | 209.9K | +25% | +$83.6K |
| DT | 2024-10-16 | 2024-10-14 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale+OE | $26.27 | -51.1K | 160.3K | -24% | -$1.34M |
| DT | 2024-04-03 | 2024-04-01 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | S - Sale | $32.12 | -4,534 | 169.6K | -3% | -$145.6K |
| 2024-04-02 | 2024-03-31 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres | A - Grant | $0.00 | +35.0K | 174.2K | +25% | $0 | |
| D | 2023-10-24 | 2023-10-20 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +90.9K | 139.2K | +188% | +$60.9K |
| DMT | 2023-07-25 | 2023-07-21+ | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $7.22 | +92.5K | 49.5K | New | +$667.8K |
| DMT | 2023-07-25 | 2023-07-21+ | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $32.06 | -156.5K | 48.2K | -76% | -$5.02M |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale | $29.73 | -3,672 | 114.0K | -3% | -$109.2K |
| D | 2023-03-31 | 2023-03-31 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | A - Grant | $0.00 | +20.0K | 116.0K | +21% | $0 |
| DM | 2023-01-05 | 2023-01-03 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $37.46 | -53.7K | 96.0K | -36% | -$2.01M |
| DM | 2023-01-05 | 2023-01-03 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.9558 | +53.7K | 105.1K | +105% | +$51.4K |
| D | 2023-01-03 | 2022-12-30 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +4,500 | 96.0K | +5% | +$3,015 |
| DM | 2022-12-14 | 2022-12-12 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $42.70 | -51.0K | 110.8K | -32% | -$2.18M |
| DM | 2022-12-14 | 2022-12-12 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $1.81 | +26.9K | 133.8K | +25% | +$48.7K |
| 2022-04-04 | 2022-03-31 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale | $59.11 | -1,859 | 115.6K | -2% | -$109.9K | |
| 2022-04-04 | 2022-03-31 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | A - Grant | $0.00 | +15.0K | 117.5K | +15% | $0 | |
| D | 2021-12-30 | 2021-12-29 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +39.7K | 102.5K | +63% | +$26.6K |
| DM | 2021-12-23 | 2021-12-22 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $86.13 | -2,607 | 63.1K | -4% | -$224.5K |
| D | 2021-12-23 | 2021-12-22 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $7.22 | +2,607 | 65.4K | +4% | +$18.8K |
| DM | 2021-12-22 | 2021-12-20+ | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $85.62 | -29.4K | 62.8K | -32% | -$2.52M |
| DM | 2021-12-22 | 2021-12-20+ | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $7.22 | +29.4K | 67.1K | +78% | +$212.2K |
| D | 2021-09-21 | 2021-09-17 | BEAM | Beam Therapeutics Inc. | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +18.0K | 62.8K | +40% | +$12.1K |
Purchase Sale Sale after option exercise All abbreviations